Literature DB >> 29308393

Some Facts on Incidence and Mortality of Cancer in Iran.

Mahdi Mohammadian1,2, Hamid Salehiniya3, Abdollah Mohammadian-Hafshejani4.   

Abstract

Entities:  

Year:  2017        PMID: 29308393      PMCID: PMC5750361     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor-in-Chief

Cancer is one of the most common causes of death and health problems in the world (1). However, this illness diagnosed in the both sexes, all the ages’ group and races, the incidence and mortality of cancer are considerably different in various geographic areas. Based on WHO worldwide report’s on the cancer epidemic, the number of death for cancer in 2005 was 7.6 million which increased to 8.2 million in 2012 (2). Based on the first national cancer’ reports, the number of new cancer cases in Iran was 55855 in 2005. Cancer is the third common cause of death after cardiovascular disease and accidents in Iran (3) and leads to 50000 annual deaths (4). Based on the GLOBOCAN project data in Iran in 2012, 84822 newly diagnosed cancer observed (Age-Standardized Incidence Rates (ASIR) was 127.7 per 100000), developed in 44838 men (ASIR= 134.7) and 39991 women (ASIR=120.1). Cancers with the highest incident rate are including Breast, Stomach, Prostate, Colorectal and Esophagus cancer (Table 1 and Fig. 1) (5). Furthermore, in 2012 in Iranian population, 53350 death was reported because of cancer (Age-Standardized Mortality Rate (ASMR) was 81.9 per 100000), divided to 30115 men (ASMR= 90.4) and 23235 women (ASMR 72.7). The highest cause of mortality in this population was due to Stomach, Breast, Esophagus, Lung and Colorectal cancer, respectively (Table 1 and Fig. 1) (5). In Iranian, the risk (%) of getting cancer before age 75 is 13.1%, which is higher in men (9.4%) in comparison with women (7.8%) (2, 5).
Table 1:

Cancers with the highest ASIR and ASMR in Iran in 2012

MeasuresMaleFemaleBoth sexes
IncidenceCancerNumber(ASR)CancerNumber(ASR)CancerNumber(ASR)
Stomach6640(20.6)Breast9795(28.1)Breast9795(28.1)
Bladder4277(13.2)Colorectal3352(10.5)Stomach9660(15.3)
Prostate4111(12.6)Stomach3020(9.7)Prostate7163(11.1)
Colorectal3811(11.6)Esophagus2445(8)Colorectal5343(8.6)
Lung3307(10.3)Lung1637(4.8)Esophagus5343(8.4)
MortalityStomach5665(17.3)Breast3304(9.9)Stomach8247(12.9)
Lung2950(09.1)Stomach2582(8.3)Breast3304(9.9)
Esophagus2662(08.3)Esophagus2253(7.4)Esophagus4915(7.8)
Colorectal2267(06.9)Colorectal1995(6.3)Lung4361(6.9)
Prostate2297(06.2)Lung1411(4.5)Colorectal4262(6.6)

Extracted from GLOBALCAN 2012

Fig. 1:

Cancers with The highest ASIR and ASMR in Iran in 2012

Cancers with the highest ASIR and ASMR in Iran in 2012 Extracted from GLOBALCAN 2012 Cancers with The highest ASIR and ASMR in Iran in 2012 Due to some factors including; increased society members awareness about signs and symptoms of cancer, advance in diagnosis technic and equipment, improved cancer record system, increase in exposure to cancer risk factors, inactive lifestyle, changes in dietary habits and increasing proportion of elderly in the community, the incidence rate of cancer is increasing trend in Iranian population (6). In hence, health authorities and policy makers should plan for preventing or decreasing society exposure to common risk factors for cancer such as smoking, obesity, and sedentary lifestyle. Moreover, with consideration of increasing trend of cancer in Iran, planning and providing for advanced diagnostic tools and treatment centers and training experts can be an important priority for the national health system. To with expected increase in the incidence of the disease over the future years, the country's health system is able to offer health services at all levels of health care. Consequently, in addition to reducing the cancer incidence rate, case fatality rate and cause-specific mortality rate of cancer reduced.
  5 in total

1.  Incidence of cancers in Kuzestan province of iran: trend from 2004 to 2008.

Authors:  Neda Amoori; Masoud Mirzaei; Maria Cheraghi
Journal:  Asian Pac J Cancer Prev       Date:  2014

2.  Cancer incidence and mortality in Iran.

Authors:  S M Mousavi; M M Gouya; R Ramazani; M Davanlou; N Hajsadeghi; Z Seddighi
Journal:  Ann Oncol       Date:  2008-12-10       Impact factor: 32.976

3.  A 10-year study of esophageal cancer in Guilan province, Iran: the Guilan Cancer Registry Study (GCRS).

Authors:  Fariborz Mansour-Ghanaei; Abtin Heidarzadeh; Mohammad Reza Naghipour; Farahnaz Joukar; Ali Kord Valeshabad; Mohammad-Sadegh Fallah; Seyed Mahmoud Rezvani; Massih Sedigh-Rahimabadi; Hasan Rokhshad; Arsalan Dadashi
Journal:  Asian Pac J Cancer Prev       Date:  2012

4.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

5.  Time Trend Analysis of Cancer‏ Incidence in Caspian Sea, 2004 - 2009: A Population-based Cancer Registries Study (northern Iran).

Authors:  Hamid Salehiniya; Sakineh Ghobadi Dashdebi; Hosein Rafiemanesh; Abdollah Mohammadian-Hafshejani; Mostafa Enayatrad
Journal:  Caspian J Intern Med       Date:  2016
  5 in total
  4 in total

1.  The prevalence of depression and anxiety in patients with cancer in Iran: a systematic review and meta-analysis.

Authors:  Niloufar Darvishi; Hooman Ghasemi; Zahra Rahbaralam; Puneh Shahrjerdi; Hakimeh Akbari; Masoud Mohammadi
Journal:  Support Care Cancer       Date:  2022-10-12       Impact factor: 3.359

2.  Rocky Road Ahead Of Nursing Presence in the Oncology Care Unit: A Qualitative Study.

Authors:  Fereshteh Araghian Mojarad; Leila Jouybari; Akram Sanagoo
Journal:  Open Access Maced J Med Sci       Date:  2018-11-20

3.  Ten-year data analysis of digestive system malignancies in Babol, North of Iran: 2008-2017.

Authors:  Leili Sadeghi Amiri; Novin Nikbakhsh; Mostafa Javanian; Simin Mouodi; Tahere Mousavi; Sedigheh Alijanpour; Fattaneh Vala; Mostafa Mirzad; Javad Shokri Shirvani; Hoda Shirafkan
Journal:  Caspian J Intern Med       Date:  2022

Review 4.  The Economic Burden of Cancer in Iran during 1995-2019: A Systematic Review.

Authors:  Aziz Rezapour; Shahin Nargesi; Fateme Mezginejad; Asma Rashki Kemmak; Rafat Bagherzadeh
Journal:  Iran J Public Health       Date:  2021-01       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.